aluates Reports

$ 0.0

Automative

Endoscope + Radiofrequency Ablation (RFA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-27Z1669

Global Endoscope Radiofrequency Ablation RFA Market Insights and Forecast to 2028

BUY CHAPTERS

Endoscope + Radiofrequency Ablation (RFA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-27Z1669

Report

September 2024

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Plc (Covidien Plc)

Smith and Nephew plc

Stryker Corporation

Halyard Health

Abbott Laboratories (St. Jude Medical, Inc.)

AngioDynamics

Hologic Inc

AtriCure

Boston Scientific Corporation Conmed Corporation

Endoscope + Radiofrequency Ablation (RFA) - Market Size

The global market for Endoscope + Radiofrequency Ablation (RFA) was estimated to be worth US$ 3575.2 million in 2023 and is forecast to a readjusted size of US$ 5339.2 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Endoscope + Radiofrequency Ablation (RFA) - Market

Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.

The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Endoscope + Radiofrequency Ablation (RFA), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Endoscope + Radiofrequency Ablation (RFA) by region & country, by Type, and by Application.

The Endoscope + Radiofrequency Ablation (RFA) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscope + Radiofrequency Ablation (RFA).

Market Segmentation

Scope of Endoscope + Radiofrequency Ablation (RFA) - Market Report

Report Metric	Details
Report Name	Endoscope + Radiofrequency Ablation (RFA) - Market
Forecasted market size in 2030	US$ 5339.2 million
CAGR	5.4%
Forecasted years	2024 - 2030
Segment by Type:	Focal Ablation Others
Segment by Application	Cardiology Application Pain Management Oncology Application Other Application
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation, Halyard Health, Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Hologic, AtriCure
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Endoscope + Radiofrequency Ablation (RFA) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Endoscope + Radiofrequency Ablation (RFA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Endoscope + Radiofrequency Ablation (RFA) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Endoscope + Radiofrequency Ablation (RFA) - Market size in 2030?

Ans: The Endoscope + Radiofrequency Ablation (RFA) - Market size in 2030 will be US$ 5339.2 million.

Who are the main players in the Endoscope + Radiofrequency Ablation (RFA) - Market report?

Ans: The main players in the Endoscope + Radiofrequency Ablation (RFA) - Market are Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation, Halyard Health, Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Hologic, AtriCure

What are the Application segmentation covered in the Endoscope + Radiofrequency Ablation (RFA) - Market report?

Ans: The Applications covered in the Endoscope + Radiofrequency Ablation (RFA) - Market report are Cardiology Application, Pain Management, Oncology Application, Other Application

What are the Type segmentation covered in the Endoscope + Radiofrequency Ablation (RFA) - Market report?

Ans: The Types covered in the Endoscope + Radiofrequency Ablation (RFA) - Market report are Focal Ablation, Others

Recommended Reports

Endoscopic Devices

RF Ablation Systems

Cancer & Tumor Ablation

1 Market Overview

1.1 Endoscope + Radiofrequency Ablation (RFA) Product Introduction

1.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Forecast

1.3 Endoscope + Radiofrequency Ablation (RFA) Market Trends & Drivers

1.3.1 Endoscope + Radiofrequency Ablation (RFA) Industry Trends

1.3.2 Endoscope + Radiofrequency Ablation (RFA) Market Drivers & Opportunity

1.3.3 Endoscope + Radiofrequency Ablation (RFA) Market Challenges

1.3.4 Endoscope + Radiofrequency Ablation (RFA) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Endoscope + Radiofrequency Ablation (RFA) Players Revenue Ranking (2023)

2.2 Global Endoscope + Radiofrequency Ablation (RFA) Revenue by Company (2019-2024)

2.3 Key Companies Endoscope + Radiofrequency Ablation (RFA) Manufacturing Base Distribution and Headquarters

2.4 Key Companies Endoscope + Radiofrequency Ablation (RFA) Product Offered

2.5 Key Companies Time to Begin Mass Production of Endoscope + Radiofrequency Ablation (RFA)

2.6 Endoscope + Radiofrequency Ablation (RFA) Market Competitive Analysis

2.6.1 Endoscope + Radiofrequency Ablation (RFA) Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Endoscope + Radiofrequency Ablation (RFA) Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoscope + Radiofrequency Ablation (RFA) as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Focal Ablation

3.1.2 Others

3.2 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type

3.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value, by Type (2019-2030)

3.2.3 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cardiology Application

4.1.2 Pain Management

4.1.3 Oncology Application

4.1.4 Other Application

4.2 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application

4.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value, by Application (2019-2030)

4.2.3 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region

5.1.1 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (2019-2024)

5.1.3 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (2025-2030)

5.1.4 Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

5.2.2 North America Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

5.3.2 Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

5.4.2 Asia Pacific Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

5.5.2 South America Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

5.6.2 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Endoscope + Radiofrequency Ablation (RFA) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Endoscope + Radiofrequency Ablation (RFA) Sales Value

6.3 United States

6.3.1 United States Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.3.2 United States Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.4.2 Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.5.2 China Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.5.3 China Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.6.2 Japan Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.7.2 South Korea Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.8.2 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019-2030

6.9.2 India Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

6.9.3 India Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Boston Scientific Corporation Conmed Corporation

7.1.1 Boston Scientific Corporation Conmed Corporation Profile

7.1.2 Boston Scientific Corporation Conmed Corporation Main Business

7.1.3 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.1.4 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.1.5 Boston Scientific Corporation Conmed Corporation Recent Developments

7.2 Medtronic Plc (Covidien Plc)

7.2.1 Medtronic Plc (Covidien Plc) Profile

7.2.2 Medtronic Plc (Covidien Plc) Main Business

7.2.3 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.2.4 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.2.5 Medtronic Plc (Covidien Plc) Recent Developments

7.3 Smith and Nephew Plc

7.3.1 Smith and Nephew Plc Profile

7.3.2 Smith and Nephew Plc Main Business

7.3.3 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.3.4 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.3.5 Stryker Corporation Recent Developments

7.4 Stryker Corporation

7.4.1 Stryker Corporation Profile

7.4.2 Stryker Corporation Main Business

7.4.3 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.4.4 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.4.5 Stryker Corporation Recent Developments

7.5 Halyard Health

7.5.1 Halyard Health Profile

7.5.2 Halyard Health Main Business

7.5.3 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.5.4 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.5.5 Halyard Health Recent Developments

7.6 Abbott Laboratories (St. Jude Medical, Inc.)

7.6.1 Abbott Laboratories (St. Jude Medical, Inc.) Profile

7.6.2 Abbott Laboratories (St. Jude Medical, Inc.) Main Business

7.6.3 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.6.4 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.6.5 Abbott Laboratories (St. Jude Medical, Inc.) Recent Developments

7.7 AngioDynamics

7.7.1 AngioDynamics Profile

7.7.2 AngioDynamics Main Business

7.7.3 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.7.4 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.7.5 AngioDynamics Recent Developments

7.8 Hologic

7.8.1 Hologic Profile

7.8.2 Hologic Main Business

7.8.3 Hologic Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.8.4 Hologic Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.8.5 Hologic Recent Developments

7.9 AtriCure

7.9.1 AtriCure Profile

7.9.2 AtriCure Main Business

7.9.3 AtriCure Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

7.9.4 AtriCure Endoscope + Radiofrequency Ablation (RFA) Revenue (US$ Million) & (2019-2024)

7.9.5 AtriCure Recent Developments

8 Industry Chain Analysis

8.1 Endoscope + Radiofrequency Ablation (RFA) Industrial Chain

8.2 Endoscope + Radiofrequency Ablation (RFA) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Endoscope + Radiofrequency Ablation (RFA) Sales Model

8.5.2 Sales Channel

8.5.3 Endoscope + Radiofrequency Ablation (RFA) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Medtronic Plc (Covidien Plc)

Smith and Nephew plc

Stryker Corporation

Halyard Health

Abbott Laboratories (St. Jude Medical, Inc.)

AngioDynamics

Hologic Inc

AtriCure

Boston Scientific Corporation Conmed Corporation

List of Tables

Table 1. Endoscope + Radiofrequency Ablation (RFA) Market Trends

Table 2. Endoscope + Radiofrequency Ablation (RFA) Market Drivers & Opportunity

Table 3. Endoscope + Radiofrequency Ablation (RFA) Market Challenges

Table 4. Endoscope + Radiofrequency Ablation (RFA) Market Restraints

Table 5. Global Endoscope + Radiofrequency Ablation (RFA) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Endoscope + Radiofrequency Ablation (RFA) Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Endoscope + Radiofrequency Ablation (RFA) Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Endoscope + Radiofrequency Ablation (RFA) Product Type

Table 9. Key Companies Time to Begin Mass Production of Endoscope + Radiofrequency Ablation (RFA)

Table 10. Global Endoscope + Radiofrequency Ablation (RFA) Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoscope + Radiofrequency Ablation (RFA) as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Endoscope + Radiofrequency Ablation (RFA) Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Endoscope + Radiofrequency Ablation (RFA) Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Endoscope + Radiofrequency Ablation (RFA) Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Endoscope + Radiofrequency Ablation (RFA) Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (2019-2024) & (%)

Table 27. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Endoscope + Radiofrequency Ablation (RFA) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2025-2030) & (US$ Million)

Table 31. Boston Scientific Corporation Conmed Corporation Basic Information List

Table 32. Boston Scientific Corporation Conmed Corporation Description and Business Overview

Table 33. Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 34. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Boston Scientific Corporation Conmed Corporation (2019-2024)

Table 35. Boston Scientific Corporation Conmed Corporation Recent Developments

Table 36. Medtronic Plc (Covidien Plc) Basic Information List

Table 37. Medtronic Plc (Covidien Plc) Description and Business Overview

Table 38. Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 39. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Medtronic Plc (Covidien Plc) (2019-2024)

Table 40. Medtronic Plc (Covidien Plc) Recent Developments

Table 41. Smith and Nephew Plc Basic Information List

Table 42. Smith and Nephew Plc Description and Business Overview

Table 43. Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 44. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Smith and Nephew Plc (2019-2024)

Table 45. Smith and Nephew Plc Recent Developments

Table 46. Stryker Corporation Basic Information List

Table 47. Stryker Corporation Description and Business Overview

Table 48. Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 49. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Stryker Corporation (2019-2024)

Table 50. Stryker Corporation Recent Developments

Table 51. Halyard Health Basic Information List

Table 52. Halyard Health Description and Business Overview

Table 53. Halyard Health Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 54. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Halyard Health (2019-2024)

Table 55. Halyard Health Recent Developments

Table 56. Abbott Laboratories (St. Jude Medical, Inc.) Basic Information List

Table 57. Abbott Laboratories (St. Jude Medical, Inc.) Description and Business Overview

Table 58. Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 59. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Abbott Laboratories (St. Jude Medical, Inc.) (2019-2024)

Table 60. Abbott Laboratories (St. Jude Medical, Inc.) Recent Developments

Table 61. AngioDynamics Basic Information List

Table 62. AngioDynamics Description and Business Overview

Table 63. AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 64. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of AngioDynamics (2019-2024)

Table 65. AngioDynamics Recent Developments

Table 66. Hologic Basic Information List

Table 67. Hologic Description and Business Overview

Table 68. Hologic Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 69. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of Hologic (2019-2024)

Table 70. Hologic Recent Developments

Table 71. AtriCure Basic Information List

Table 72. AtriCure Description and Business Overview

Table 73. AtriCure Endoscope + Radiofrequency Ablation (RFA) Products, Services and Solutions

Table 74. Revenue (US$ Million) in Endoscope + Radiofrequency Ablation (RFA) Business of AtriCure (2019-2024)

Table 75. AtriCure Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Endoscope + Radiofrequency Ablation (RFA) Downstream Customers

Table 79. Endoscope + Radiofrequency Ablation (RFA) Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Endoscope + Radiofrequency Ablation (RFA) Product Picture

Figure 2. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value (2019-2030) & (US$ Million)

Figure 4. Endoscope + Radiofrequency Ablation (RFA) Report Years Considered

Figure 5. Global Endoscope + Radiofrequency Ablation (RFA) Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Endoscope + Radiofrequency Ablation (RFA) Revenue in 2023

Figure 7. Endoscope + Radiofrequency Ablation (RFA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Focal Ablation Picture

Figure 9. Others Picture

Figure 10. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Cardiology Application

Figure 13. Product Picture of Pain Management

Figure 14. Product Picture of Oncology Application

Figure 15. Product Picture of Other Application

Figure 16. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Endoscope + Radiofrequency Ablation (RFA) Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Endoscope + Radiofrequency Ablation (RFA) Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Endoscope + Radiofrequency Ablation (RFA) Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Endoscope + Radiofrequency Ablation (RFA) Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Endoscope + Radiofrequency Ablation (RFA) Sales Value (%), (2019-2030)

Figure 29. United States Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 35. China Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 37. China Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 47. India Endoscope + Radiofrequency Ablation (RFA) Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Endoscope + Radiofrequency Ablation (RFA) Sales Value by Type (%), 2023 VS 2030

Figure 49. India Endoscope + Radiofrequency Ablation (RFA) Sales Value by Application (%), 2023 VS 2030

Figure 50. Endoscope + Radiofrequency Ablation (RFA) Industrial Chain

Figure 51. Endoscope + Radiofrequency Ablation (RFA) Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tumor Radiofrequency Ablation Market Insights Forecast to 2030

Global Radiofrequency Ablation Market Insights Forecast to 2030

Global Radiofrequency Ablation for Cardiology Market Insights Forecast to 2030

Global Radiofrequency Ablation Therapy Device Market Research Report 2025

Global RF Ablation System Market Research Report 2024

Global Radiofrequency Therapy Instrument Market Research Report 2025

Global Radiofrequency Ablation Varicose Vein Treatment Device Market Research Report 2024

Global Radiofrequency Ablation Devices for Pain Management Market Research Report 2025

Global RFA Varicose Vein Treatment Device Market Research Report 2024

Plasma Radiofrequency Ablation Machine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radio Frequency Ablation Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radio Frequency Ablation System Market Research Report 2024

Global Radiofrequency Ablation Instrument Market Research Report 2024

Global Radiofrequency Electrosurgical Device Market Research Report 2025

Global Electrophysiology EP Radiofrequency RF Ablation Catheter Market Research Report 2025

Global Medical RF Systems Market Research Report 2025

Global Arthroscopy RF System Market Research Report 2024

Global Cardiac or Radiofrequency RF Ablation Catheter Market Research Report 2025

Medical Radio Frequency Ablation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions